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Abstract
In addition to its contribution to bone metabolism, vitamin D seems to fulfill a 
broad spectrum of biological functions which justifies the interest in monitoring 
its body content. The aim of this study is to analyze the prevalence of hypovi-
taminosis D and associated factors in schoolchildren and adolescents living in a 
region of northern Spain. A cross-sectional clinical and analytical study (calcium, 
phosphorus, calcidiol, and parathyroid hormone) was accomplished in a group of 
602 Caucasian individuals (aged 3.1–15.4 years). Gender, age, body mass index, 
residence, and season of the year were recorded, and their association with vitamin 
D deficiency was analyzed by multiple regression. Vitamin D status was defined 
according to the US Endocrine Society criteria. The prevalence of hypovitaminosis 
D was 60.4% (insufficiency: 44.6%; deficiency: 15.8%). The female sex, adoles-
cence, season of blood sample collection (autumn, winter, and spring), an urban 
residence, and severe obesity showed an association with an increased risk of 
hypovitaminosis D.
Keywords: associated factors, calcidiol, children, deficiency, insufficiency, 
prevalence, sufficiency, vitamin D
1. Introduction
Vitamin D (cholecalciferol) is a hormone that is basically synthesized in the skin 
after exposure to sunlight. This substance undergoes initial hepatic (25-OH-D or 
calcidiol) and subsequent renal [1, 25-(OH)2-D or calcitriol] hydroxylation before 
the definitive functional activation. The stimulation of ultraviolet radiation (type 
B) promotes the endogenous synthesis of vitamin D from epidermal 7-dehydrocho-
lesterol, which is the main source of vitamin D, whereas dietary sources account for 
less than 10% of the total. The function in bone metabolism and calcium homeosta-
sis has been long considered and known. Vitamin D deficiency causes a reduction in 
the absorption of dietary calcium and an increase in parathyroid hormone (PTH) 
secretion with the aim to keep steady levels of serum calcium. A deficiency in vita-
min D produces osteoclastic activity and causes loss of bone mineral density [1–6].
Recent studies have shown the presence of vitamin D receptors in the majority 
of organs (blood vessels, B and T lymphocytes, heart, muscles, skin, brain, mam-
mary gland, colon, prostate, gonads, etc.) and the activity of specific enzymes that 
are not regulated by PTH and induce calcitriol synthesis. All these findings reveal 
the biological significance of vitamin D. In fact, several observational studies have 
suggested that vitamin D deficiency could be related to a higher cardiovascular risk, 
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as well as a risk to present autoimmune, endocrine, infectious, psychiatric, and/or 
neurological diseases and several types of cancer [1, 4, 7–13]. Additional studies are 
needed to evaluate the underlying mechanisms.
In other words, in addition to its contribution to bone metabolism, vitamin D 
seems to fulfill a broad spectrum of biological functions related to cell prolifera-
tion, differentiation, and metabolism, which justifies the interest in monitoring its 
body content. Gender, age, race, season of the year in which serum is collected, sun 
exposure, and nutritional status have been associated with lower levels of serum 
calcidiol, but there are disparities among the different authors in the interpretation 
of these findings [7, 9, 14–20].
The aim of this study is to determine the prevalence of hypovitaminosis D and 
associated factors among children in northern Spain.
2. Materials and methods
2.1 Participants
The present work is a cross-sectional study conducted in a sample of 602 indi-
viduals from ages 3.1 to 15.4 years after the completion of a clinical examination and 
blood testing in the period January 2014 to December 2014. Tests were carried out 
in the Pediatric Endocrinology Unit of our hospital. Tanner’s criteria were evaluated 
in every individual and were used in the assignment of individuals in two different 
groups: school group (Tanner stage I) and adolescent group (Tanner stages II–V). 
The characteristics of the place of residence were recorded as urban or rural (< 
or > 10,000 inhabitants, respectively).
All individuals were healthy Caucasian children living in Navarra, Spain. They 
were selected from the external consultations of the different pediatric subspecial-
ties and were not affected by any chronic pathology with potential interference in 
growth, body composition, food ingestion, or physical activity. Any participant 
under treatment with concrete medications (antiepileptic drugs or glucocorticoids), 
vitamin D, or calcium supplements was put aside from our sample.
2.2 Clinical examination
Body measurements (weight and height) were taken in specific conditions 
(underwear, barefoot). An Año-Sayol scale (reading interval 0–120 kg and a 
precision of 100 g) was used for weight registration and a Holtain wall stadiometer 
(reading interval 60–210 cm, precision 0.1 cm) for height registration. The program 
Aplicación Nutricional, from the Spanish Society of Pediatric Gastroenterology, 
Hepatology and Nutrition (Sociedad Española de Gastroenterología, Hepatología y 
Nutrición Pediátrica, available at http://www.gastroinf.es/nutritional/), provided 
the estimates of the Z-score values of BMI. The reference charts used for compari-
son were the graphics from Ferrández et al. (Centro Andrea Prader, Zaragoza 2002).
The values of Z-score enabled the assignment of individuals in the following groups:
• Normal: Z-score between −1.0 (15th percentile) and + 1.0 (85th percentile)
• Overweight: Z-score > 1.0 (85th percentile)
• Obesity: Z-score > 2.0 (97th percentile)
• Severe obesity: Z-score > 3.0 (99th percentile)
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2.3 Blood testing
The plasma levels of calcium and phosphorous were determined in a fasting 
sample of blood using colorimetric methods in a cobas 8000 analyzer (Roche 
Diagnostic, Mannheim, Germany). The determination of calcidiol levels required 
a high-specific chemiluminescence immunoassay (LIAISON Assay, Diasorin, 
Dietzenbach, Germany) and the determination of PTH levels a highly specific 
solid-phase, two-site chemiluminescent enzyme-labeled immunometric assay in an 
Immulite analyzer (DPC Biermann, Bad Nauheim, Germany).
The distribution of individuals according to Vitamin D plasma levels followed 
the criteria of the US Endocrine Society [21, 22]. Calcidiol plasma levels lower 
than 20 ng/ml (<50 nmol/L) corresponded to Vitamin D deficiency, calcidiol 
levels between 20 and 29 ng/ml (50–75 nmol/L) to Vitamin D insufficiency, and 
concentrations equal to or higher than 30 ng/ml (>75 nmol/L) to Vitamin D suf-
ficiency. PTH serum levels higher than 65 pg/ml [14, 17] determined secondary 
hyperparathyroidism.
2.4 Statistical analysis
The figures resulting from the data collection are shown as percentages (%) and 
means (M) including the respective standard deviations (SD) or confidence inter-
vals (95% CI). The subsequent statistical analysis (descriptive statistics, Student’s 
t-test, analysis of variance, χ2 test, Pearson’s correlation, and multiple logistic 
regression analysis) was performed using the software package Statistical Packages 
for the Social Sciences version 20.0 (Chicago, IL, USA). A probability value (p-value) 
<0.05 was established as the level of statistical significance.
Adequate information of the proceedings and potential implications was 
delivered to the parents and/or legal guardians, and the corresponding consent was 
required prior to the inclusion in this study in all cases. The study was presented 
and approved after the evaluation of the Ethics Committee for Human Investigation 
at our institution (in line with the ethical standards stated in the Declaration of 
Helsinki, 1964, and later amendments).
3. Results
The average values for calcidiol and PTH plasma levels from the totality of the 
collections were 27.4 ± 7.7 ng/mL and 33.2 ± 17.3 pg/mL, respectively. Calcidiol levels 
overtook 30 ng/mL (Vitamin D sufficiency) in 236 individuals (39.6%), oscillated 
between 20 and 29 ng/mL (Vitamin D insufficiency) in 266 (44.6%), and were lower 
than 20 ng/mL (Vitamin D deficiency) in 94 (15.8%). The average values for calcium 
and phosphorus were 9.9 ± 0.5 and 4.6 ± 0.5 mg/dL, respectively. No values for 
hypo-/hypercalcemia or hypo-/hyperphosphatemia were detected. The frequency of 
hyperparathyroidism was significantly higher in the deficient vitamin D (11.6%) and 
insufficient vitamin D (6.6%) groups, whereas the prevalence of hyperparathyroid-
ism was lowest in the sufficient vitamin D (2.3%) group (p = 0.005).
Table 1 shows the distribution of the presumed risk factors for hypovitaminosis 
D (sex, age group, place of residence, season of blood sample collection, and nutri-
tion status).
Table 2 shows and compares the mean values for the clinical characteristics and 
biochemical determinations according to the risk factors for hypovitaminosis D. Mean 
PTH values were significantly higher (p < 0.05) in females. The average phosphorous 
values were significantly higher in males (p < 0.05). No significant differences were 
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detected in age, nutrition situation, calcium, and calcidiol after the comparison 
between sexes. Calcidiol and phosphorus levels were significantly higher (p < 0.05) 
in the school group, whereas the average values for PTH were significantly higher in 
adolescents (p < 0.05). There were not any significant differences in Calcium levels 
between the age groups. Those individuals whose residence was in rural areas showed 
mean values for calcium and calcidiol significantly higher, whereas those individuals 
living in urban areas had PTH mean values significantly higher. There were no signifi-
cant differences regarding age, BMI (Z-score), and phosphorous among individuals 
living in both areas. The lowest calcidiol levels corresponded to spring (26.1 ± 6.2 ng/
mL), and they reached a maximum in the summer (34.5 ± 8.0 ng/mL); meanwhile, 
the lowest parathyroid hormone levels corresponded to summer (26.6 ± 10.1 pg./mL) 
and reached a maximum value in autumn (37.8 ± 17.2 pg./mL). There were not any 
significant differences in calcium and phosphorus levels in each season. Mean values 
of calcidiol and PTH were significantly lower and higher (p < 0.05), respectively, in 
the group of severe obesity than in other groups with different nutritional situations 
(normal, overweight, and obesity). There were no significant differences in calcidiol 
and phosphorous mean values among the different groups.
Table 3 exposes and compares the prevalence of the different calcidiol levels 
in relation to analyzed associated factors in hypovitaminosis D. We did not detect 
significant differences in the prevalence of the different levels in calcidiol status in 
relation to sex. However, the prevalence of vitamin D deficiency was significantly 
higher in the group of adolescents with respect to school children and rural environ-
ment. In the same way, individuals with severe obesity showed a prevalence of vita-
min D deficiency significantly higher than those in different nutritional situations.
Item N (%)
Sex
Female 340 (43.5%)
Male 262 (56.5%)
Age group
Child 299 (49.7%)
Adolescent 303 (50.3%)
Residence
Urban 394 (65.6%)
Rural 207 (34.4%)
Season of study
Winter 180 (29.9%)
Spring 131 (21.8%)
Summer 106 (17.6%)
Autumn 185 (30.7%)
Nutritional status
Normal weight 393 (67.3%)
Overweight 69 (11.8%)
Obesity 68 (11.6%)
Severe obesity 54 (9.2%)
Table 1. 
Demographics and clinical characteristics of the participants in the study.
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Item Age (years) BMI (Z-score) Calcium (mg/dl) Phosphorus (mg/dl) Calcidiol (ng/ml) PTH (pg/ml)
Sex
Females 9.88 ± 3.18 0.47 ± 1.69 10.01 ± 0.37 4.52 ± 0.59 26.88 ± 7.75 35.72 ± 18.46
Males 9.98 ± 3.44 0.41 ± 2.10 9.98 ± 0.36 4.71 ± 0.57 27.98 ± 7.69 29.90 ± 15.27
Significance (p) 0.720 0.720 0.348 <0.001 0.083 <0.001
Age group
School 7.19 ± 2.08 0.17 ± 1.78 10.01 ± 0.38 4.73 ± 0.54 28.50 ± 7.44 30.87 ± 15.42
Adolescent 12.62 ± 1.62 0.71 ± 2.2 9.97 ± 0.34 4.47 ± 0.61 26.22 ± 7.86 35.58 ± 18.91
Significance (p) <0.001 <0.001 0.157 <0.001 <0.001 <0.001
Residence
Urban 10.06 ± 3.28 0.44 ± 2.11 9.97 ± 0.35 4.60 ± 0.58 26.46 ± 7.74 34.49 ± 17.64
Rural 9.67 ± 3.31 0.47 ± 1.85 10.05 ± 0.37 4.61 ± 0.60 29.02 ± 7.47 30.89 ± 16.76
Significance (p) 0.171 0.885 0.008 0.807 <0.001 0.019
Season
Winter 9.78 ± 3.07 0.49 ± 2.5 10.04 ± 0.33 4.57 ± 0.56 26.54 ± 7.39 31.02 ± 18.03
Spring 10.24 ± 3.14 0.55 ± 1.74 10.02 ± 0.37 4.61 ± 0.56 26.11 ± 6.25 32.28 ± 18.05
Summer 10.44 ± 3.28 0.46 ± 2.73 9.97 ± 0.29 4.66 ± 0.64 34.52 ± 8.05 26.65 ± 10.06
Autumn 9.65 ± 3.56 0.33 ± 1.85 9.93 ± 0.40 4.60 ± 0.59 26.26 ± 7.42 37.88 ± 17.21
Significance (p) 0.182 0.806 0.119 0.731 <0.001 <0.001
Nutritional status
Normal 9.62 ± 3.34 −0.64 ± 0.94 9.98 ± 0.36 4.59 ± 0.57 28.18 ± 7.7 31.11 ± 15.58
Overweight 10.43 ± 2.6 1.37 ± 0.29 10.02 ± 0.38 4.62 ± 0.55 27.65 ± 7.35 33.12 ± 16.25
Obesity 11.09 ± 2.4 2.46 ± 0.28 10.05 ± 0.36 4.66 ± 0.62 26.19 ± 7.01 39.9 ± 20.26
Severe obesity 11.1 ± 3.28 4.66 ± 2.24 9.96 ± 0.36 4.54 ± 0.72 23.09 ± 8.24 45.22 ± 22
Significance (p) <0.001 <0.001 0.447 0.721 <0.001 <0.001
Table 2. 
Clinical and biochemical characteristics according to the presumed risk factors for hypovitaminosis D (M ± DE).
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Figure 1 presents the prevalence of hypovitaminosis D (deficiency and insuf-
ficiency) according to the seasons of the year in healthy pediatric population. The 
levels of vitamin D during summer was sufficient in 80% of the individuals; this 
level substantially decreased in autumn and winter (hypovitaminosis was detected 
in 65.6% and 62.7% during autumn and winter, respectively) and got to the lowest 
point in spring, a period that revealed a prevalence of hypovitaminosis of 72.7%.
Item Deficiency
N (%)
Insufficiency
N (%)
Sufficiency
N (%)
Chi2 (p)
Sex
Females 56 (16.7%) 161 (47.9%) 119 (35.4%) 5.65 (0.059)
Males 38 (14.6%) 105 (40.4%) 117 (45%)
Age group
School 31 (11.1%) 131 (44.3%) 132 (44.6%) 11.696 (0.003)
Adolescent 61 (20.3%) 135 (45%) 104 (34.7%)
Residence
Urban 75 (19.3%) 175 (45%) 139 (35.7%) 12.671 (0.002)
Rural 19 (9.2%) 91 (44.2%) 96 (46.6%)
Season
Winter 40 (21.1%) 79 (41.6%) 71 (37.4%)
Spring 17 (13.3%) 76 (59.4%) 35 (27.3%) 69.12 (<0.001)
Summer 4 (5.3%) 11 (14.7%) 60 (80%)
Autumn 33 (16.3%) 100 (49.3%) 70 (34.5%)
Nutritional status
Normal 46 (11.8%) 176 (45.1%) 168 (43.1%)
Overweight 11 (15.9%) 27 (39.1%) 31 (44.9%) 30.135 (<0.001)
Obesity 12 (18.2%) 33 (50%) 21 (31.8%)
Severe obesity 20 (37.7%) 23 (43.4%) 10 (18.9%)
Table 3. 
Prevalence of the different calcidiol levels in relation to the presumed risk factors for hypovitaminosis D.
Figure 1. 
Prevalence of vitamin D status according to seasons.
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Figure 2 states the average values for calcidiol levels along the months of the 
year (ANOVA, p < 0.001), showing the highest levels during the summer months 
(July: 32.6 ng/mL, CI 95%: 29.7–35.5; August: 33.6 ng/mL, CI 95%: 31.2–36; and 
September: 33.5 ng/mL, CI 95%: 31.4–35.6); in contrast, these levels were lower 
during the winter and spring months.
Figure 3 presents the PTH levels (average) in the different months of the year 
(ANOVA, p < 0.001). The autumn months show the highest PTH levels (October: 
39.8 pg/mL, CI 95%: 35.4–43.6; November: 37.1 pg/mL, CI 95%: 34.1–34.1; and 
December: 36.0, CI 95%: 31.7–40.3) and the end of spring (May: 32.8 pg/mL, CI 
95%: 29.0–36.6 and June: 33.0 pg/mL, CI 95%: 29.0–37.0); in contrast, these levels 
were lower in the summer months (July: 25.1 pg/mL, CI 95%: 21.9–28.3 and August: 
26.1 pg/mL, CI 95%: 23.0–29.2).
A significant correlation (p < 0.001) between calcidiol and parathyroid hor-
mone levels (r = −0.24) was observed; calcium and PTH plasma levels (r = −0.20) 
are also correlated. A significant correlation was detected between age and calcidiol 
levels (r = −0.15) and also between age and PTH levels (r = 0.18).
Table 4 illustrates the multiple logistic regression analysis for the presumed pre-
dictors of vitamin D status. The female sex, adolescence, season of blood sample col-
lection (autumn, winter, and spring), an urban residence, and severe obesity showed 
an association with an increased risk of vitamin D insufficiency. Adolescence, season 
of blood sample collection (autumn and winter), urban residence, and severe obesity 
revealed an association with an increased risk of vitamin D deficiency.
Figure 2. 
Calcidiol levels (ng/ml ± CI 95%) throughout the year (ANOVA, p < 0.001).
Figure 3. 
PTH levels (pg/ml ± CI 95%) in the different months of the year (ANOVA, p < 0.001).
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4. Discussion
There is a high prevalence of hypovitaminosis D in the pediatric population in 
our environment, which potentially represents a serious public health problem. The 
criteria from the US Endocrine Society have been used for the comparison of the 
results with the previous published data. According to these criteria, calcidiol has a 
long half-life (2 to 3 weeks) and is the best indicator of body vitamin D content; they 
consider normal serum levels when they reach 30 ng/mL or higher and hypovitamin-
osis D below this level. In this way, hypovitaminosis is classified into insufficiency 
(between 21 and 29 ng/mL) and deficiency (lower than 20 ng/mL) [4, 21, 22].
The blood sample analysis shows the following prevalence: vitamin D suf-
ficiency in 39.6% of the individuals, insufficiency 44.6% and deficiency 15.8%, 
respectively. These results might seem to show a high prevalence of hypovitaminosis 
for a healthy population, but are indeed relatively moderate in comparison to other 
studies published in different areas or latitudes of our planet (Table 5); this may 
Items Deficiency OR (IC 95%)
p
Insufficiency OR (CI 95%)
p
Sex
Males 1 (reference) 1 (reference)
Females 1.1 (0.9–1.8)
0.676
1.6 (1.1–2.3)
0.011
Age group
School 1 (reference) 1 (reference)
Adolescent 2.0 (1.2–3.4)
0.005
1.8 (1.2–2.6)
0.003
Season
Summer 1 (reference) 1 (reference)
Autumn 3.8 (1.3–11.5)
0.018
9.5 (4.8–18.7)
<0.001
Winter 5.8 (1.9–17.4)
0.002
8.8 (4.5–17.5)
<0.001
Spring 3.1 (0.9–9.9)
0.058
13.2 (6.4–27.5)
<0.001
Residence
Rural 1 (reference) 1 (reference)
Urban 2.4 (1.4–4.0)
0.020
1.6 (1.1–2.2)
0.01
Nutritional status
Normal 1 (reference) 1 (reference)
Overweight 1.3 (0.7–1.8)
0.442
0.8 (0.5–1.4)
0.476
Obesity 1.3 (0.7–2.8)
0.443
1.2 (0.7–2.2)
0.498
Severe obesity 4.4 (2.2–8.6)
<0.001
4.4 (1.9–10.3)
<0.001
Table 4. 
Multiple logistic regression analysis for the presumed risk factor for hypovitaminosis (deficiency and 
insufficiency).
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be due to the fact that in this study their participants were exclusively of Caucasian 
origin, since, as is well known, the difference in skin pigmentation in different 
ethnic groups implies a higher risk of hypovitaminosis D [14, 17, 18, 28, 32, 34–37].
Calcidiol measurements—even though they were not significant—were higher 
in males, whereas PTH levels were significantly higher in females, but there were 
no significant differences in the prevalence of hypovitaminosis D among sexes. 
Previously published data are inconsistent [9, 34, 38, 39]. Nevertheless, the logistic 
regression analysis revealed that hypovitaminosis D, and more specifically the level 
of insufficiency, was significantly associated with females. Adolescents (pubertal 
group) had significantly lower calcidiol levels than school children, but the mean 
values for PTH and the prevalence of hypovitaminosis D were significantly higher 
in that group, and these results match those provided by other authors [17, 40]. 
Furthermore, the logistic regression analysis showed that hypovitaminosis D, as 
insufficiency and deficiency, was significantly associated to the older group. These 
findings could be somehow disturbing, since adolescence is a key period for grow-
ing, development, and bone formation, when vitamin D requirements are increased 
and deficiency may affect normal bone mass acquisition. Individuals living in 
urban areas had calcidiol values significantly lower than those living in rural areas, 
whereas PTH values and prevalence of vitamin D deficiency were significantly 
higher in those individuals from urban areas. These findings might be related to the 
different lifestyles inherent to the different environment, since residents in rural 
areas are likely to experience longer periods of sun exposure, as several authors have 
highlighted [17, 19].
The characteristics of sun exposure depend considerably on the location. In this 
way, it has been found how the axial tilt (obliquity) of our planet in the northern 
hemisphere (beyond 37th parallel—north), mainly in the colder months of the 
year, causes a change in the density of incident rays and, therefore, the ultraviolet 
radiation (type B) decreases up to 80–100%. That is the reason why sun radiation 
is not able to lead to efficient vitamin D synthesis [14, 17, 29, 41]. Hence the main 
reasons of vitamin D deficiency are usually in direct relation either to any physical 
agents that obstruct sun radiation (cutaneous pigmentation, sunscreens, etc.) or to 
Authors Deficiency Insufficiency Sufficiency
Cheng et al., 2003 (Jyväskylä, Finland) [23] 32% 46% 22%
Weng et al., 2007 (Philadelphia, USA) [14] 26% 29% 45%
Gordon et al., 2008 (Boston, USA) [24] 12% 40% 48%
Kelly et al., 2011 (Filadelfia, USA) [25] 47% 27% 26%
Andiran et al., 2012 (Ankara, Turkey) [26] 40% — —
Tolppanen et al., 2012 (England, UK) [27] 29% 46% 25%
González-Cross et al., 2012 (Europe) [28] 19% 39% 42%
Vierucci et al., 2013 (Toscana, Italy) [17] 46% 34% 20%
Karagüzel et al., 2014 (Trabzon, Turkey) [29] 71% 23% 6%
Durá-Travé et al., 2015 (Navarra, Spain) [30] 13% 45% 42%
Kaddam et al., 2017 (Saudi Arabia) [31] 49% 46% 5%
Fernández-Bustillo et al., 2018 (Galicia, Spain) [32] 5.9% 60.1% 34%
Guo et al., 2018 (China) [33] 10.8% 39% 50.2%
Table 5. 
Prevalence of hypovitaminosis D according to different authors.
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geographical features, such as sunlight exposure, atmospheric pollution, altitude, 
latitude, and the season of the year [1, 3].
The negative correlation between calcidiol and parathyroid hormone plasma 
levels has been previously described by different authors [14, 17, 33, 42]; nonetheless, 
the discussion about the combined oscillations existing among both hormones along 
a natural year has not been that intense [43, 44]. The analysis of our data has shown 
simultaneous and asynchronous changes in parathyroid hormone levels with respect 
to calcidiol, simultaneously with monthly and/or seasonal modifications in calcidiol 
levels. These adjustments presumably would take place in order to maintain constant 
calcium levels along the year, as we have noticed in this study. In point of fact, the 
highest body vitamin D levels are detected in the summer months—there is a more 
intense sunlight exposure. The levels decrease gradually in the autumn and winter 
months—except for some biological variability—and they reach the lowest point in 
springtime. By comparison to the findings of other authors [3, 17, 29], only 18.2% of 
the 602 individuals classified in the status of vitamin D insufficiency of deficiency 
presented with PTH levels within the range of hyperparathyroidism; since no 
diagnosis of hypercalcemia or hypocalcaemia or any bone semiology was previously 
described, a potential conclusion is that seasonal changes in calcidiol and parathy-
roid hormone levels would be related to a physiological phenomenon of adaptation 
to the geographical and climatic conditions endemic to this region. Navarre is a 
Spanish region located on a high latitude (between 41°55″22 N and 43°16″42 N) with 
frequent cloudy and rainy days, and this characteristic is important enough to take 
into consideration that cyclical variation in calcidiol levels in relation to the season 
of the year could be explained by a possible inefficient vitamin synthesis induced by 
sun radiation, as several authors have noted [14, 17, 24, 29, 42, 45–47]. Admittedly, 
the results confirm that vitamin D levels in the summer months were sufficient in 
80% of the individuals. They moderately decrease in the months of autumn and 
winter (the percentage of individual in a situation of hypovitaminosis D gets to 66.6 
and 62.7% in autumn and winter, respectively) and fall to the lowest point in spring 
months, when the prevalence of hypovitaminosis gets to 72.7%.
Because geographical and climatic conditions significantly influence body 
vitamin D content and, secondarily, PTH plasma levels, a comparison of the differ-
ent results obtained in the published works from different countries and/or climatic 
conditions would be unwise and faulty, since the place of residence, latitude, and 
especially the month of the year when the blood sample is collected always have to 
be considered. In other words, it is not possible to establish a vitamin D status in a 
concrete population without considering the seasonal variations because, as this 
work has shown, a potential condition of hypovitaminosis D is related to the season 
of the year in which the determination has been made [48, 49].
As BMI (Z-score) increases, calcidiol values decrease and PTH significantly 
rises, in a way that individuals with severe obesity showed minimum values of cal-
cidiol and maximum values of PTH with respect to the individuals of the remaining 
nutritional situations. This means, there seems to be a noticeable tendency to pres-
ent with vitamin D deficiency in the individuals with severe obesity [9, 20, 40, 50]; 
this eventuality has been outlined as a cardiovascular and/or metabolic risk factor 
[4, 8–10, 15, 19]. Even though there is not a conclusive explanation in this respect, 
it has been suggested that this circumstance in obese individuals may be related to 
environmental factors (decreased sun exposure as a consequence of a sedentary life-
style, inadequate diet, etc.), although, at present, some authors postulate a hypo-
thetical “sequestration” or excessive accretion of vitamin D in the adipose tissue 
[2, 4, 7, 8, 16, 18, 21, 42]. Previous reports did not distinguish between obesity and 
severe obesity, as we did in this work, and this special feature could be of practical 
relevance, since the logistic regression analysis has verified that hypovitaminosis 
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D, in levels of insufficiency as well as deficiency, is significantly associated to the 
nutritional situation of severe obesity.
The development of this study unveiled several limitations. The main weak-
nesses are the cross-sectional nature of the study and the absence of data on 
exercise, sun exposure, and the use of sunscreens. There have been some dif-
ficulties to get adequate and accurate data, and it restrained us from completing 
the registration. A nutritional survey (including dietary vitamin D intake, daily 
supplementation, etc.) was not incorporated in the study. Our experience reflects 
that dairy product intake in our social context is below the recommended amount 
and particularly fish intake is quite low in the pediatric population [51]; in this way, 
only the dietary supplementation of vitamin D could condition the results achieved, 
but, at present, it is not a widespread practice in our society.
Given the difficulties in maintaining a sufficient body vitamin D content in 
the pediatric age group throughout the year, the prevention, detection, and, when 
required, treatment and follow-up of hypovitaminosis should be fully integrated in 
the programs of health promotion and disease prevention in child and adolescent 
population corresponding to primary health care. In other words, primary care teams 
and, more specifically, pediatricians should include a series of preventive measures—
in addition to the mandatory vitamin D daily supplementation during the first year 
of life, 400 UI per day [4, 52, 53], such as promoting adequate sun exposure, in the 
service portfolio. Around 10–15 minutes of midday sun exposure (between 10 in the 
morning and 3 in the afternoon) on at least 20% of total body surface (uncovered 
head and extremities) during spring, summer, and autumn is considered enough to 
get an adequate vitamin D synthesis [2]. In addition, in case any of the hypovitamino-
sis D-associated factors is present, especially in those individuals at risk of limited sun 
exposure (disabled and/or undergoing long stay in the hospital, etc.), the need for 
additional vitamin D supplementation should be considered, either as pharmacologi-
cal supplements (600 IU per day), an increase of the ingestion of higher amounts 
from its natural dietary sources (herring, salmon, sardines, tuna, etc.), or vitamin D 
fortified foods (dairy products, cereals, etc.) during the months of winter and spring, 
as several authors have suggested [6, 12, 14, 15, 18, 21, 28, 34, 54].
5. Conclusion
There is a high prevalence of hypovitaminosis D in the pediatric population in 
our environment, being female sex, pubertal age, the seasons of autumn, winter and 
spring, living in urban area, and severe obesity considered as associated factors in 
hypovitaminosis D. Consideration should be given to the administration of vitamin 
supplements and/or the increase in the ingestion of natural vitamin D dietary sources.
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